5051 to 5100 MCQs for Lab Technician and Technologist Exam Preparation
5000 Plus MCQs for Lab Technician and Technologists are designed to test the knowledge and proficiency of laboratory professionals who work in the field of clinical laboratory science. These questions cover a wide range of topics related to laboratory science, including anatomy, physiology, microbiology, chemistry, and hematology.

If You like then share this to your friends and other social media.
If You have any question and suggestions then please Contact us Here
Questions 5051 to 5100
- a) Leucine
- b) Glutamate
- c) Lysine
- d) Threonine
Why other options are incorrect:
- • Leucine: It is a non-polar, branched-chain amino acid with only one amino group.
- • Glutamate: It is an acidic amino acid; it contains two carboxyl groups, not two amino groups.
- • Threonine: It is a polar uncharged amino acid that contains one amino group and one hydroxyl (-OH) group.
- a) Primary structure
- b) Secondary structure
- c) Tertiary structure
- d) Quaternary structure
Why other options are incorrect:
- • Secondary structure: This structure (alpha-helices and beta-sheets) is maintained by hydrogen bonds which are easily disrupted during denaturation.
- • Tertiary structure: This is the overall folding of a single polypeptide chain, which is lost when the protein denatures.
- • Quaternary structure: This refers to the arrangement of multiple polypeptide subunits; these subunits dissociate when a protein is denatured.
- a) Isoleucine
- b) Alanine
- c) Leucine
- d) Valine
Why other options are incorrect:
- • Isoleucine: It is one of the three essential branched-chain amino acids with a branched hydrocarbon side chain.
- • Leucine: It is a major branched-chain amino acid known for its role in protein synthesis and muscle repair.
- • Valine: It is a branched-chain amino acid characterized by its “V” shaped branched side chain.
- a) Serine
- b) Arginine
- c) Lysine
- d) Proline
Why other options are incorrect:
- • Arginine: This is a basic amino acid with a guanidino group in its side chain, not a hydroxyl group.
- • Lysine: This is a basic amino acid characterized by an epsilon-amino group in its side chain.
- • Proline: This is an imino acid where the side chain forms a rigid ring structure with the nitrogen atom of the amino group; it does not have an -OH group.
- a) Phenylisothiocyanate
- b) 1-Fluoro-2, 4-dinitrobenzene
- c) Dansyl Chloride
- d) tBOC azide
Why other options are incorrect:
- • 1-Fluoro-2, 4-dinitrobenzene: This is known as Sanger’s reagent, used for N-terminal analysis but it results in the hydrolysis of the entire peptide.
- • Dansyl Chloride: This is a fluorescent reagent used to label the N-terminal amino groups of proteins and peptides for detection.
- • tBOC azide: (tert-Butyloxycarbonyl azide) is used as a protecting group for amino groups during chemical peptide synthesis.
- a) Determine the number of tyrosine residues in a protein
- b) Determine the number of aromatic amino acid residues in a protein
- c) Determine the amino acid sequence of a protein
- d) Hydrolyse the peptide bonds in a protein
Why other options are incorrect:
- • Tyrosine residues: Specific quantification of tyrosine is usually done using spectrophotometry or specific reagents like Millon’s reagent.
- • Aromatic residues: While aromatic residues are detected during sequencing, Edman’s reaction is not a general test for the “number” of aromatic residues; absorption at 280nm is typically used for that.
- • Hydrolyse peptide bonds: Edman’s reaction is highly selective for the N-terminus; broad hydrolysis of all peptide bonds is typically achieved using strong acid (like 6M HCl) or proteolytic enzymes.
- a) Tay-Sachs disease
- b) Metachromatic leukodystrophy
- c) Gaucher’s disease
- d) Multiple sclerosis
Why other options are incorrect:
- • Tay-Sachs disease: Caused by a deficiency of the enzyme Hexosaminidase A, leading to the accumulation of GM2 gangliosides.
- • Metachromatic leukodystrophy: Caused by a deficiency of the enzyme Arylsulfatase A, leading to the accumulation of sulfatides.
- • Multiple sclerosis: This is an autoimmune inflammatory disease where the immune system attacks the protective sheath (myelin) that covers nerve fibers; it is not caused by a specific inherited enzyme deficiency.
- a) Arylsulphatase A
- b) Hexosaminidase A
- c) Sphingomyelinase
- d) Ceramidase
Why other options are incorrect:
- • Arylsulphatase A: Deficiency of this enzyme causes Metachromatic leukodystrophy.
- • Sphingomyelinase: Deficiency of this enzyme causes Niemann-Pick disease (Types A and B).
- • Ceramidase: Deficiency of acid ceramidase leads to Farber disease (lipogranulomatosis).
- a) Apo E
- b) Apo B-48
- c) Apo B-100
- d) Apo A-I
Why other options are incorrect:
- • Apo E: A much smaller protein (approximately 299 amino acids) involved in the transport of lipids.
- • Apo B-48: This is a truncated version of Apo B-100, representing only the N-terminal 48% of the protein; it is produced in the intestine.
- • Apo A-I: The major protein component of HDL, it is significantly smaller than Apo B-100 (approximately 243 amino acids).
- a) Adipose tissue
- b) Liver
- c) Intestine
- d) Liver and intestine
Why other options are incorrect:
- • Adipose tissue: This tissue functions primarily in the storage and release of fatty acids, not in the synthesis of B-type apolipoproteins.
- • Intestine: The intestine synthesizes Apo B-48. Although both proteins come from the same gene, RNA editing in the intestinal cells creates a stop codon that results in the shorter Apo B-48 version.
- • Liver and intestine: This is incorrect because B-100 is specific to the liver, while B-48 is specific to the intestine.
- a) Adipose tissue
- b) Liver
- c) Intestine
- d) Liver and intestine
Why other options are incorrect:
- • Adipose tissue: This tissue stores fat but does not synthesize the apolipoproteins required for lipoprotein particle assembly.
- • Liver: The liver synthesizes Apo B-100, the full-length version used in VLDL and LDL. While the gene is the same, mRNA editing only happens in the intestine to produce B-48.
- • Liver and intestine: This is incorrect because the synthesis is highly site-specific: the liver only makes B-100, and the intestine only makes B-48.
- a) LDL only
- b) LDL and VLDL
- c) HDL only
- d) HDL and chylomicrons
Why other options are incorrect:
- • LDL only: LDL primarily contains Apo B-100, not Apo A-I and A-II.
- • LDL and VLDL: These lipoproteins are mainly associated with Apo B-100.
- • HDL and chylomicrons: Apo A-I and Apo A-II are characteristic of HDL; chylomicrons mainly contain Apo B-48 along with other apolipoproteins.
- a) Chylomicrons
- b) VLDL
- c) LDL
- d) HDL
Why other options are incorrect:
- • VLDL: Very Low-Density Lipoproteins contain Apo B-100, which is synthesized in the liver.
- • LDL: Low-Density Lipoproteins are derived from VLDL and IDL, and thus also contain Apo B-100 as their primary structural protein.
- • HDL: High-Density Lipoproteins do not contain B-type apolipoproteins; they primarily contain Apo A-I and Apo A-II.
- a) Chylomicrons
- b) VLDL only
- c) LDL only
- d) VLDL and LDL
Why other options are incorrect:
- • Chylomicrons: These contain Apo B-48, which is the truncated version of the protein synthesized in the intestine.
- • VLDL only: While VLDL does contain B-100, the statement is incorrect because B-100 remains on the particle as it matures into IDL and eventually LDL.
- • LDL only: LDL contains B-100, but it is not the only particle that does; it inherits B-100 from its precursor, VLDL.
- a) Chylomicrons
- b) VLDL
- c) HDL
- d) All of these
Why other options are correct:
- • Chylomicrons: Contain Apo C-I, C-II, and C-III.
- • VLDL: Contains Apo C-I, C-II, and C-III.
- • HDL: Contains Apo C-I, C-II, and C-III and serves as an important reservoir for Apo C proteins.
- a) Chylomicrons
- b) VLDL
- c) LDL
- d) HDL
Why other options are incorrect:
- • Chylomicrons: They acquire Apo C-II and C-III from HDL while circulating in the blood to facilitate the breakdown of fats.
- • VLDL: These particles contain the Apo C family to activate Lipoprotein Lipase (LPL) for triglyceride delivery to tissues.
- • HDL: HDL serves as a circulating reservoir for the Apo C proteins, donating them to and receiving them back from other lipoproteins.
- a) Enzyme activator
- b) Ligand for receptor
- c) Both (Enzyme activator) and (Ligand for receptor)
- d) None of these
Why other options are incorrect:
- • Enzyme activator only: This is incomplete because Apo A-I also has structural and receptor-binding roles.
- • Ligand for receptor only: This is incomplete because its role in activating the LCAT enzyme is one of its most critical biological functions.
- • None of these: Incorrect, as Apo A-I is one of the most biologically active apolipoproteins with clearly defined roles as both an activator and a ligand.
- a) Enzyme activator
- b) Ligand for receptor
- c) Both (Enzyme activator) and (Ligand for receptor)
- d) None of these
Why other options are incorrect:
- • Enzyme activator: Unlike Apo C-II (which activates Lipoprotein Lipase) or Apo A-I (which activates LCAT), Apo B-100 does not function as an enzyme activator.
- • Both: Since Apo B-100 does not have a recognized role as an enzyme activator, this option is incorrect.
- • None of these: Incorrect, as the role of Apo B-100 as a ligand for the LDL receptor is one of the most important concepts in lipid metabolism and atherosclerosis.
- a) Lecithin cholesterol acyl transferase
- b) Phospholipase C
- c) Extrahepatic lipoprotein lipase
- d) Hepatic lipoprotein lipase
Why other options are incorrect:
- • Lecithin cholesterol acyl transferase (LCAT): This enzyme is primarily activated by Apolipoprotein A-I, not Apo C-II.
- • Phospholipase C: This is an enzyme involved in intracellular signaling (IP3/DAG pathway) and is not regulated by plasma apolipoproteins.
- • Hepatic lipoprotein lipase: Also known as Hepatic Lipase (HL), this enzyme functions in the liver to convert IDL to LDL and process HDL; unlike LPL, it does not require Apo C-II for its activity.
- a) VLDL remnant
- b) VLDL
- c) LDL
- d) HDL
Why other options are incorrect:
- • VLDL / VLDL remnant: These are part of the endogenous lipid pathway; while VLDL also carries C and E, it does not serve as the donor reservoir for chylomicrons.
- • LDL: LDL is a “terminal” lipoprotein that has lost its exchangeable apolipoproteins (C and E) and primarily contains only Apo B-100.
- • HDL: Is the correct donor because it is specifically designed to exchange these proteins back and forth with triglyceride-rich lipoproteins.
- a) Removes nucleotides from 3’ end
- b) Adds nucleotides at 3’ end
- c) Removes nucleotides from 5’ end
- d) Adds nucleotides at 5’ end
Why other options are incorrect:
- • Removes nucleotides from 3’ end: This is the function of a 3′ to 5′ exonuclease, which acts as a “proofreader” or degradation enzyme.
- • Removes nucleotides from 5’ end: This is the function of a 5′ to 3′ exonuclease.
- • Adds nucleotides at 5’ end: Biological DNA synthesis and transferase activity almost exclusively occur by adding new nucleotides to the 3′-hydroxyl group of the sugar-phosphate backbone.
- a) DNA of somatic cells
- b) DNA of sperms
- c) Any double stranded DNA
- d) Any single stranded DNA
Why other options are incorrect:
- • DNA of somatic/sperm cells: Nucleases are generally classified by the structure of the nucleic acid they target (single vs. double stranded), not the specific cell type the DNA originated from.
- • Any double stranded DNA: S1 nuclease is specifically chosen because it leaves double-stranded DNA (dsDNA) intact under standard reaction conditions. Enzymes like DNase I would be used to hydrolyze double-stranded DNA.
- a) Starvation
- b) Wasting diseases
- c) Growing age
- d) Intestinal malabsorption
Why other options are incorrect:
- • Starvation: Leads to a negative nitrogen balance because the body breaks down muscle protein to provide energy and glucose.
- • Wasting diseases: Chronic illnesses or cancers cause significant tissue breakdown (catabolism), resulting in more nitrogen being excreted than consumed.
- • Intestinal malabsorption: Since the body cannot effectively absorb dietary protein, it enters a state of protein deficiency and negative nitrogen balance.
- a) Glutamate and α-ketoglutarate
- b) Pyruvate and glutamate
- c) Pyruvate and α-ketoglutarate
- d) Aspartate and α-ketoglutarate
Why other options are incorrect:
- • Glutamate and α-ketoglutarate: These two are the amino donor/keto-acid pair for many reactions, but without a 3-carbon skeleton like pyruvate, alanine cannot be formed.
- • Pyruvate and α-ketoglutarate: Both of these are keto-acids. To synthesize an amino acid like alanine, you need an amino group donor (like glutamate), not two keto-acids.
- • Aspartate and α-ketoglutarate: This reaction is catalyzed by AST and produces Oxaloacetate and Glutamate, not alanine.
- a) Pyruvate
- b) α-ketoglutarate
- c) Glutamate
- d) Pyridoxal phosphate
Why other options are incorrect:
- • Pyruvate: This is the 3-carbon keto-acid that provides the structural skeleton for alanine.
- • Glutamate: This is the amino acid that donates the amino (-NH2) group to pyruvate to form alanine.
- • Pyridoxal phosphate (PLP): This is the active form of Vitamin B6 and is an essential cofactor for all transaminase enzymes; without it, the reaction cannot take place.
- a) It is non-essential amino acid
- b) It is a dicarboxylic amino acid
- c) It can be synthesized from pyruvate and glutamate
- d) It can be converted into asparagine
Why other options are correct:
- • Non-essential amino acid: The human body can synthesize aspartate from metabolic intermediates (Oxaloacetate), so it is not required in the diet.
- • Dicarboxylic amino acid: Aspartate contains two carboxyl (-COOH) groups (one alpha-carboxyl and one side-chain carboxyl), making it an acidic amino acid.
- • Converted into asparagine: Aspartate is the precursor for asparagine; the enzyme asparagine synthetase adds an amino group to the side chain of aspartate to form asparagine.
- a) Serine
- b) Choline
- c) Betaine
- d) All of these
Why other options are correct:
- • Serine: Serine is the major precursor of glycine via serine hydroxymethyltransferase.
- • Choline: Choline can contribute to glycine synthesis through its metabolism to betaine and subsequent one-carbon reactions.
- • Betaine: Betaine participates in one-carbon metabolism and can contribute to glycine formation.
- a) Glutamate
- b) Ammonia
- c) Pyridoxal phosphate
- d) ATP
Why other options are incorrect :
- • Glutamate: It serves as the carbon skeleton/substrate for the reaction.
- • Ammonia: It provides the amide group required to turn glutamate into glutamine.
- • ATP: The reaction is endergonic and requires the cleavage of ATP into ADP and Pi to proceed.
- Note on Pyridoxal phosphate (PLP): While PLP is a vital cofactor for transaminases, it is NOT involved in the glutamine synthetase reaction.
- a) ATP
- b) Pyridoxal phosphate
- c) Tetrahydrofolate
- d) NAD
Why other options are incorrect:
- • ATP: Not required as the coenzyme for the serine-to-glycine conversion.
- • Pyridoxal phosphate: Although PLP is involved in many amino acid reactions, it is not the required coenzyme for this conversion.
- • NAD: Not required for the direct conversion of serine to glycine.
- a) It is an imino acid
- b) It can be synthesized from glutamate
- c) It can be catabolised to glutamate
- d) Free proline can be hydroxylated to hydroxyproline
Why other options are correct:
- • It is an imino acid: Proline has a secondary amino group and is traditionally classified as an imino acid.
- • It can be synthesized from glutamate: Proline can be synthesized from glutamate through several enzymatic steps.
- • It can be catabolised to glutamate: Proline degradation produces glutamate as a metabolic end product.
- a) Prolamin
- b) Procollagen
- c) Collagen
- d) Proinsulin
Why other options are incorrect:
- • Prolamin: These are a group of plant storage proteins (found in cereal grains) rich in proline and glutamine, but not hydroxyproline.
- • Procollagen: While procollagen is the precursor that contains hydroxyproline, “Collagen” is the definitive mature structural protein known for this composition in a clinical/biochemical context.
- • Proinsulin: This is the prohormone precursor to insulin and does not contain hydroxyproline.
- a) There is no codon for hydroxyproline
- b) It is present in large amounts in collagen
- c) Free proline cannot be hydroxylated to hydroxyproline
- d) Hydroxylation of proline residues is catalysed by a dioxygenase
Why other options are correct:
- • There is no codon for hydroxyproline: Hydroxyproline is formed by post-translational hydroxylation of proline.
- • It is present in large amounts in collagen: Hydroxyproline is an abundant amino acid derivative in collagen and contributes to its stability.
- • Hydroxylation of proline residues is catalysed by a dioxygenase: Prolyl hydroxylase is an Fe²⁺- and vitamin C-dependent dioxygenase.
- a) Ascorbic acid
- b) Glutamate
- c) Ferrous ions
- d) Molecular oxygen
Why other options are incorrect:
- • Ascorbic acid: Maintains the iron in the reduced Fe²⁺ state required for prolyl hydroxylase activity.
- • Ferrous ions: Serve as an essential cofactor for prolyl hydroxylase.
- • Molecular oxygen: Is required for the hydroxylation reaction.
- a) Serine
- b) Homoserine
- c) Homocysteine
- d) Threonine
Why other options are incorrect:
- • Homoserine: This is an intermediate in the synthesis of threonine and methionine in plants/bacteria, but not the precursor for cysteine in humans.
- • Homocysteine: While homocysteine is an intermediate derived from methionine, it cannot form cysteine by itself; it must react with Serine to do so.
- • Threonine: Threonine is an essential amino acid and is not involved in providing the carbon backbone for cysteine synthesis.
- a) Cysteine and homoserine
- b) Homocysteine and serine
- c) Cysteine and serine
- d) None of these
Why other options are incorrect:
- • Cysteine and homoserine: This pathway occurs in plants and bacteria to synthesize methionine, but not in humans.
- • Homocysteine and serine: This combination is used to synthesize Cysteine (via the transsulfuration pathway), not methionine.
- • Regeneration: While the body can recycle homocysteine back into methionine (remethylation) using Vitamin B12 and Folate, it cannot synthesize the original homocysteine skeleton from the combinations listed above.
- a) Phenylalanine hydroxylase
- b) Tetrahydrobiopterin
- c) NADH
- d) Molecular oxygen
Why other options are incorrect:
- • Phenylalanine hydroxylase: The enzyme that catalyzes the conversion of phenylalanine to tyrosine.
- • Tetrahydrobiopterin: Acts as the essential cofactor for phenylalanine hydroxylase.
- • Molecular oxygen: One oxygen atom is incorporated into tyrosine during the hydroxylation reaction.
- a) Ornithine
- b) β-alanine
- c) γ-amino butyric acid
- d) All of these
Why other options are incorrect:
- • Ornithine: A non-protein amino acid involved in the urea cycle.
- • β-alanine: A non-protein amino acid and a component of coenzyme A.
- • γ-amino butyric acid: GABA is a non-protein amino acid that functions as an inhibitory neurotransmitter.
- a) Alanine
- b) Aspartate
- c) Glutamate
- d) Glutamine
Why other options are incorrect:
- • Alanine: Primarily undergoes transamination to form pyruvate.
- • Aspartate: Mainly undergoes transamination to form oxaloacetate.
- • Glutamine: Undergoes hydrolysis by glutaminase to produce glutamate and ammonia rather than direct oxidative deamination.
- a) ATP
- b) ADP
- c) AMP
- d) GMP
Why other options are incorrect:
- • ADP: Acts as an allosteric activator of glutamate dehydrogenase.
- • AMP: It is not the principal allosteric inhibitor of glutamate dehydrogenase.
- • GMP: It is not the principal allosteric inhibitor of glutamate dehydrogenase.
- a) ATP
- b) GTP
- c) ADP and GDP
- d) AMP and GMP
Why other options are incorrect:
- • ATP: ATP is an allosteric inhibitor of glutamate dehydrogenase.
- • GTP: GTP also acts as an inhibitor of glutamate dehydrogenase.
- • AMP and GMP: These are not the principal allosteric activators of glutamate dehydrogenase.
- a) Oxidative deamination of glutamate
- b) Catabolism of purines
- c) Catabolism of pyrimidines
- d) All of these
Why other options are incorrect:
- • Oxidative deamination of glutamate: Glutamate is deaminated by glutamate dehydrogenase, releasing free ammonia.
- • Catabolism of purines: Breakdown of purine-containing compounds can release ammonia.
- • Catabolism of pyrimidines: Pyrimidine degradation can also produce ammonia as a nitrogen-containing product.
- a) Liver
- b) Brain
- c) Kidney
- d) Heart
Why other options are incorrect:
- • Liver: The liver detoxifies ammonia by converting it into urea through the urea cycle.
- • Kidney: The kidney participates in ammonia metabolism and excretion but is not as sensitive to ammonia toxicity as the brain.
- • Heart: The heart is not the primary organ affected by ammonia toxicity.
- a) Free ammonia
- b) Glutamine
- c) Asparagine
- d) Alanine
Why other options are incorrect:
- • Free ammonia: Ammonia is toxic and is not transported in significant amounts as free ammonia in the blood.
- • Glutamine: Glutamine is an important transport form of ammonia from many tissues, but muscle nitrogen is classically transported to the liver mainly as alanine.
- • Asparagine: It is not the major transport form of ammonia from skeletal muscle to the liver.
- a) Brain
- b) Kidneys
- c) Liver
- d) Muscles
Why other options are incorrect:
- • Brain: The brain is highly sensitive to ammonia but does not have the capacity to synthesize urea to detoxify it.
- • Kidneys: The kidneys are responsible for filtering and excreting urea from the blood into urine, but they do not produce it.
- • Muscles: Muscles produce ammonia during protein metabolism, which is then sent to the liver for conversion into urea.
- a) Cytosol
- b) Mitochondria
- c) Both (Cytosol) and (Mitochondria)
- d) None of these
Why other options are incorrect:
- • Cytosol: While the later steps of the urea cycle (starting from the formation of argininosuccinate) occur in the cytosol, the initial formation of carbamoyl phosphate does not. (Note: CPS II exists in the cytosol, but it is used for pyrimidine synthesis, not the urea cycle).
- • Both: The specific reaction for the urea cycle is compartmentalized strictly within the mitochondria to keep toxic ammonia sequestered.
- a) 15–20 mg
- b) 1.5–2 gm
- c) 5–10 gm
- d) 15–20 gm
Why other options are incorrect:
- • 15–20 mg: This value is extremely low and physiologically impossible for a living human, as even during starvation, the body breaks down some protein.
- • 1.5–2 gm: This level is significantly below the average and would only be seen in cases of severe protein malnutrition or very specific low-protein therapeutic diets.
- • 5–10 gm: While closer, this range is typically associated with a low-protein intake rather than a standard balanced diet for an adult man.
- a) Sulphur-containing amino acids
- b) Aromatic amino acids
- c) Branched chain amino acids
- d) Dicarboxylic amino acids
Why other options are incorrect:
- • Sulphur-containing amino acids: Metabolism errors of these (like Methionine) lead to conditions such as Homocystinuria.
- • Aromatic amino acids: Errors in aromatic amino acids (like Phenylalanine or Tyrosine) cause conditions like Phenylketonuria (PKU) or Alkaptonuria.
- • Dicarboxylic amino acids: Amino acids like Glutamate and Aspartate are generally metabolized through different pathways and are not associated with MSUD.
- a) Metabolise cysteine
- b) Convert cystine into cysteine
- c) Incorporate cysteine into proteins
- d) Reabsorb cystine in renal tubules
Why other options are incorrect:
- • Metabolise cysteine: Cystinuria is a transport defect, not a metabolic enzyme defect. The body’s ability to break down cysteine inside cells is generally normal.
- • Convert cystine into cysteine: This is a chemical reduction process that occurs within cells; it is not the underlying cause of this condition.
- • Incorporate cysteine into proteins: Protein synthesis (translation) is not affected in individuals with cystinuria.
- a) Histidine carboxylase
- b) Histidine decarboxylase
- c) Histidase
- d) Histidine oxidase
Why other options are incorrect:
- • Histidine carboxylase: There is no major metabolic enzyme by this name in the standard histidine breakdown pathway.
- • Histidine decarboxylase: This enzyme converts histidine into histamine (a chemical involved in immune responses). While important, its deficiency does not cause histidinemia.
- • Histidine oxidase: This is not the primary enzyme involved in the metabolic error associated with classical histidinemia.
- a) Phenylalanine cannot be converted into tyrosine
- b) Urinary excretion of phenylpyruvate and phenyllactate is increased
- c) It can be controlled by giving a low-phenylalanine diet
- d) It leads to decreased synthesis of thyroid hormones, catecholamines and melanin
Why other options are correct:
- • Option a: Correct. The primary defect is a deficiency of Phenylalanine Hydroxylase, which normally converts phenylalanine to tyrosine.
- • Option b: Correct. Since the main pathway is blocked, phenylalanine is shunted to an alternative pathway, producing “phenyl-ketones” like phenylpyruvate.
- • Option c: Correct. Limiting phenylalanine intake is the standard clinical treatment to prevent brain damage and other symptoms.
Answer Key Summary
The questions are typically designed to assess the technical skills and knowledge required for the laboratory profession, including the ability to analyze laboratory test results, perform laboratory procedures, and maintain laboratory equipment.
To prepare for these MCQs, candidates should have a thorough understanding of the key concepts and principles of laboratory science. They should also be familiar with common laboratory equipment and procedures, as well as laboratory safety protocols.
Candidates may also benefit from studying specific laboratory science textbooks or taking online courses that cover the material tested in the MCQs. Additionally, practicing sample MCQs and reviewing the answers can help candidates identify areas where they may need to improve their knowledge or skills.
Overall, the MCQs for lab technologists are designed to be challenging and comprehensive, requiring candidates to demonstrate a high level of proficiency in the field of laboratory science.
